EUVIMEDAtrasti EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials

Danielle Dircks, Eh Khaing, Ahmad Aroudaky, Muaaz Almerstani, Nmair Alziadin iD, Radha P Kanneganti, James Aguto, Jmaylia Mimms, Chen Jiang iD, Lluis Mont iD, Domenico Grieco, Carina Blomstrom-Lundqvist and 16 more

Journal of Cardiovascular Electrophysiology · 2024

DOI: 10.1111/jce.16396 ↗

At a glance

Systematische Übersicht in Journal of Cardiovascular Electrophysiology, 2024. Written by Danielle Dircks and 27 co-authors. Institution: College of Medicine, University of Nebraska, Omaha, Nebraska, USA. Major MEDLINE topics: Atrial Fibrillation, Obesity, Randomized Controlled Trials as Topic, Catheter Ablation. Cited 3 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 4.0).

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

The prevalence and impact of obesity on outcomes of atrial fibrillation (AF) ablation randomized controlled trials (RCTs) have not been well studied.

Objective

To examine the proportion of participants with obesity enrolled in RCTs of AF ablation and outcomes of ablation when subgroup analysis of participants with obesity were available.

Methods

We systematically searched PubMed and EMBASE for AF ablation RCTs published between January 1, 2015 to May 31, 2022. When body mass index (BMI) data were available, normal distribution was assumed and a z score was used to estimate the proportion of obesity. Results categorized by BMI or body weight status were reviewed. Authors were contacted for additional information.

Results

Of 148 eligible RCTs with 30174 participants, 144 (97.30%) RCTs did not report the proportion of participants with obesity, while published information regarding BMI was available in 63.51%. Three trials excluded patients based on BMI. Using reported BMI, we estimated the proportion of participants with obesity varied greatly across these trials, ranging from 5.82%–71.9% (median 38.02%, interquartile 29.64%, 49.10%). Patients with obesity were represented in a greater proportion among trials conducted in North America (50.23%) and Asia (44.72%), compared to others (32.16%), p < .001. Subgroup analysis or analysis adjusting for BMI was reported in only 13 (8.78%) RCTs; four (30.77%) of these suggested that BMI or body weight might negatively affect primary outcomes.

Conclusion

Obesity is a common comorbidity among AF patients. However, most AF ablation RCTs underreported the proportion of participants with obesity and its impact on the primary outcomes.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationObesityRandomized Controlled Trials as TopicCatheter AblationBody Mass IndexHumansTreatment OutcomeMaleFemalePrevalenceMiddle AgedRisk FactorsAgedRisk AssessmentHeart Rate

Author keywords

atrial fibrillationbody mass indexcatheter ablationobesityrandomized controlled trial

Authors and institutions

  • College of Medicine, University of Nebraska, Omaha, Nebraska, USA.
  • University of Nebraska, Omaha, Nebraska, USA.
  • Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Cardiology Department, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Hospital Clínic, Universitat de Barcelona/Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain/CIBERCV, Madrid, Spain.
  • Division of Cardiology, Policlinico Casilino of Rome, Rome, Italy.

ORCID profiles: Nmair Alziadin, Chen Jiang, Lluis Mont, Karapet V Davtyan, Arash Aryana, William Schleifer

Cite

APA

Dircks, D., Khaing, E., Aroudaky, A., Almerstani, M., Alziadin, N., Kanneganti, R. P., Aguto, J., Mimms, J., Jiang, C., Mont, L., Grieco, D., Blomstrom-Lundqvist, C., Davtyan, K. V., Prabhu, S., Kistler, P., Aryana, A., Andrade, J. G., Macle, L., Schleifer, W., …, & Naksuk, N. (2024). Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16396

Vancouver

Dircks D, Khaing E, Aroudaky A, Almerstani M, Alziadin N, Kanneganti RP, et al. Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16396

BibTeX
@article{Dircks2024,
  author = {Dircks, Danielle and Khaing, Eh and Aroudaky, Ahmad and Almerstani, Muaaz and Alziadin, Nmair and Kanneganti, Radha P and Aguto, James and Mimms, Jmaylia and Jiang, Chen and Mont, Lluis and Grieco, Domenico and Blomstrom-Lundqvist, Carina and Davtyan, Karapet V and Prabhu, Sandeep and Kistler, Peter and Aryana, Arash and Andrade, Jason G and Macle, Laurent and Schleifer, William and Payne, Jason and Easley, Arthur and Khan, Faris and Windle, John and Tsai, Shane and Anderson, Daniel and Haynatzki, Gleb and Peeraphatdit, Thoetchai and Naksuk, Niyada},
  title = {Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2024},
  doi = {10.1111/jce.16396}
}
Start for free →